270 related articles for article (PubMed ID: 3291233)
1. Late cyclosporine conversion carries risk of irreversible rejection.
Sagalowsky AI; Reisman ME; Dawidson I; Toto R; Peters PC; Helderman JH
Transplant Proc; 1988 Jun; 20(3 Suppl 3):157-60. PubMed ID: 3291233
[No Abstract] [Full Text] [Related]
2. The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
Slapak M; Geoghegan T; Digard N; Ahmed K; Sharman VL; Crockett R
Transplant Proc; 1987 Apr; 19(2 Suppl 2):41-5. PubMed ID: 3551255
[No Abstract] [Full Text] [Related]
3. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I
Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
[No Abstract] [Full Text] [Related]
4. A prospective study of conversion from cyclosporine to azathioprine: comparison of clinical and morphologic findings.
Abbud-Filho M; Ramalho HJ; Barberato JB; Corrente JE; Salgueiro MC; Mazzetto MR; Bezas AG
Transplant Proc; 1988 Jun; 20(3 Suppl 3):164-8. PubMed ID: 3291235
[No Abstract] [Full Text] [Related]
5. Long-term results of cadaveric renal transplantation after conversion from cyclosporine to azathioprine: a controlled randomized trial.
Spielberger M; Aigner F; Schmid T; Bösmüller C; Königsrainer A; Margreiter R
Transplant Proc; 1988 Jun; 20(3 Suppl 3):169-70. PubMed ID: 3291236
[No Abstract] [Full Text] [Related]
6. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
Ford HR; Fryd DS; Canafax DM; Ascher NL; Dunn D; Sutherland DE; Najarian JS; Simmons RL
Transplant Proc; 1988 Jun; 20(3 Suppl 3):8-12. PubMed ID: 3291316
[No Abstract] [Full Text] [Related]
7. Conversion from cyclosporine: status after five years.
Freedman BI; Tuttle AB; Lorentz WB; Browning MC; Meredith JH; Burkart JM; Adams PL
Transplant Proc; 1991 Feb; 23(1 Pt 2):1020-2. PubMed ID: 1989144
[No Abstract] [Full Text] [Related]
8. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
Macris MP; Frazier OH; Van Buren CT; Duncan JM
Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
[No Abstract] [Full Text] [Related]
9. A prospective study of cyclosporine monitoring in renal transplantation.
Lindholm A
Transplant Proc; 1990 Jun; 22(3):1260-3. PubMed ID: 2190388
[No Abstract] [Full Text] [Related]
10. [Spontaneous kidney transplant rupture--effect of immunosuppressive therapy on incidence of rupture].
Oesterwitz H; Strobelt V; May G; Horlbeck R
Z Urol Nephrol; 1990 Apr; 83(4):157-63. PubMed ID: 2378176
[TBL] [Abstract][Full Text] [Related]
11. Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival.
Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF
Transplant Proc; 1988 Jun; 20(3 Suppl 3):152-4. PubMed ID: 3291231
[No Abstract] [Full Text] [Related]
12. Triple drug immunosuppression (cyclosporine, azathioprine and low-dose prednisolone): a safe and effective regimen in first-cadaver kidney transplantation.
Mourad G; Legendre C; Argiles A; Bonardet A; Mion C
Transplant Proc; 1987 Oct; 19(5):3672-3. PubMed ID: 3313886
[No Abstract] [Full Text] [Related]
13. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD
Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
[No Abstract] [Full Text] [Related]
14. Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation.
Fries D; Hiesse C; Santelli G; Gardin JP; Cantarovich M; Lantz O; Charpentier B; Paillard M; Benoit G
Transplant Proc; 1988 Jun; 20(3 Suppl 3):130-5. PubMed ID: 3291226
[No Abstract] [Full Text] [Related]
15. Renal transplants maintained on low-dose cyclosporine and prednisolone.
Rogerson ME; Neild GH; Rudge CJ; Wood SM; Cairns HS; Mansell MA; Thompson FD
Transplant Proc; 1988 Jun; 20(3 Suppl 3):114-6. PubMed ID: 3291222
[No Abstract] [Full Text] [Related]
16. Cyclosporine treatment with conversion after three months is a safe treatment protocol in renal allograft recipients.
Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
Transplant Proc; 1988 Jun; 20(3 Suppl 3):161-3. PubMed ID: 3291234
[No Abstract] [Full Text] [Related]
17. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
Oesterwitz H; May G; Müller P; Strobelt V; Seeger W; Seibt F; Horlbeck R; Hansen C
Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
[TBL] [Abstract][Full Text] [Related]
18. Early conversion from cyclosporine to combination therapy with azathioprine in living related kidney transplantation.
Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Yoshida T
Transplant Proc; 1989 Feb; 21(1 Pt 2):1628-30. PubMed ID: 2652531
[No Abstract] [Full Text] [Related]
19. First month cyclosporine A sparing in renal transplantation.
Segoloni GP; Messina M; Colla L; Piccoli GB; Triolo G; Vercellone A
Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249
[No Abstract] [Full Text] [Related]
20. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
